Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing
US-2016265046-A1 · Sep 15, 2016 · US
US10138509B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10138509-B2 |
| Application number | US-201414774282-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 26, 2014 |
| Priority date | Mar 12, 2013 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of making a three-dimensional matrix of nucleic acids within a cell is provided.
Opening claim text (preview).
What is claimed is: 1. A method of identifying nucleic acids within a cell, comprising: contacting a plurality of nucleic acids having a relative three-dimensional spatial relationship within the cell with a matrix-forming material in a manner to substantially retain the relative three-dimensional spatial relationship; using the matrix-forming material to form a three-dimensional polymerized matrix including the nucleic acids of the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix; and detecting signals from the nucleic acids or derivatives thereof, thereby identifying the nucleic acids. 2. The method of claim 1 further including the step of amplifying the nucleic acids to produce amplicons within the three-dimensional polymerized matrix. 3. The method of claim 2 further including the step of covalently bonding the amplicons to the three-dimensional polymerized matrix. 4. The method of claim 1 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample. 5. The method of claim 1 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell. 6. The method of claim 1 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample. 7. A method of identifying one or more nucleic acids within a cell comprising: contacting a plurality of nucleic acids having a relative three-dimensional spatial relationship within the cell with a matrix-forming material to form a three-dimensional polymerized matrix comprising the plurality of nucleic acids coupled to the three-dimensional polymerized matrix, wherein the relative three-dimensional spatial relationship is substantially retained in the three-dimensional polymerized matrix; amplifying the plurality of nucleic acids to produce amplicons within the three-dimensional polymerized matrix; coupling the amplicons to the three-dimensional polymerized matrix; and detecting the amplicons to identify a sequence of the one or more nucleic acids. 8. A method of identifying a relative three-dimensional spatial relationship of one or more nucleic acids within a cell comprising: contacting a plurality of nucleic acids having the relative three-dimensional spatial relationship within the cell with a matrix-forming material in a manner to substantially retain the relative three-dimensional spatial relationship; using the matrix-forming material to form a three-dimensional polymerized matrix including the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix; amplifying the plurality of nucleic acids to produce amplicons within the matrix, covalently bonding the amplicons to the three-dimensional polymerized matrix; labeling the amplicons with a detectable label; and imaging the amplicons to identify the relative three-dimensional spatial relationship of the one or more nucleic acids within the cell. 9. The method of claim 7 wherein the plurality of nucleic acids are circular. 10. The method of claim 7 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample. 11. The method of claim 7 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell. 12. The method of claim 7 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample. 13. The method of claim 8 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample. 14. The method of claim 8 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell. 15. The method of claim 8 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample. 16. The method of claim 1 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix. 17. The method of claim 1 wherein the matrix-forming material comprises polyacrylamide, cellulose, alginate, polyamide, cross-linked agarose, cross-linked dextran or cross-linked polyethylene glycol. 18. The method of claim 7 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix. 19. The method of claim 8 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix. 20. The method of claim 7 wherein contacting the plurality of nucleic acids having the relative three-dimensional spatial relationship within the cell with the matrix-forming material comprises subjecting the matrix-forming material to a polymerization inducing catalyst, ultraviolet (UV) light, or functional cross-linkers. 21. The method of claim 7 wherein coupling the amplicons to the three-dimensional polymerized matrix comprises covalently bonding the amplicons to the three-dimensional polymerized matrix. 22. The method of claim 7 wherein the three-dimensional polymerized matrix comprises the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix. 23. The method of claim 7 wherein the amplicons are labeled with a detectable label. 24. The method of claim 1 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking. 25. The method of claim 1 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization. 26. The method of claim 7 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking. 27. The method of claim 7 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization. 28. The method of claim 8 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking. 29. The method of claim 8 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization. 30. The method of claim 2 , wherein amplifying the nucleic acids comprises performing polymerase chain reaction (PCR) on the nucleic acids. 31. The method of claim 2 , wherein amplifying the nucleic acids comprises performing isothermal enzymatic amplification on the nucleic acids. 32. The method of claim 2 , wherein the amplicons are labeled with a detectable label. 33. The method of claim 7 , wherein amplifying the plurality of nucleic acids comprises performing PCR on the plurality of nucleic acids. 34. The method of claim 7 , wherein amplifying the plurality of nucleic acids comprises p
Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title
Nucleic acid amplification reactions · CPC title
Methods for sequencing · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.